ATE239720T1 - Heterozyklische verbindungen - Google Patents

Heterozyklische verbindungen

Info

Publication number
ATE239720T1
ATE239720T1 AT96901518T AT96901518T ATE239720T1 AT E239720 T1 ATE239720 T1 AT E239720T1 AT 96901518 T AT96901518 T AT 96901518T AT 96901518 T AT96901518 T AT 96901518T AT E239720 T1 ATE239720 T1 AT E239720T1
Authority
AT
Austria
Prior art keywords
heterocyclic compounds
chem
halogen atom
formula
halogenocyclopropyl
Prior art date
Application number
AT96901518T
Other languages
English (en)
Inventor
Makoto Takemura
Youichi Kimura
Katsuhiro Kawakami
Kenichi Kimura
Hitoshi Ohki
Norikazu Matsuhashi
Haruko Kawato
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE239720T1 publication Critical patent/ATE239720T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Earth Drilling (AREA)
  • Stereophonic System (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Pyridine Compounds (AREA)
AT96901518T 1995-02-02 1996-02-01 Heterozyklische verbindungen ATE239720T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP1561495 1995-02-02
JP1948195 1995-02-07
JP1947895 1995-02-07
PCT/JP1996/000208 WO1996023782A1 (en) 1995-02-02 1996-02-01 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ATE239720T1 true ATE239720T1 (de) 2003-05-15

Family

ID=27281082

Family Applications (2)

Application Number Title Priority Date Filing Date
AT96901518T ATE239720T1 (de) 1995-02-02 1996-02-01 Heterozyklische verbindungen
AT03000883T ATE411309T1 (de) 1995-02-02 1996-02-01 Pyridonkarbonsaüre derivate und deren verwendung als antibakterielle wirkstoffe

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03000883T ATE411309T1 (de) 1995-02-02 1996-02-01 Pyridonkarbonsaüre derivate und deren verwendung als antibakterielle wirkstoffe

Country Status (13)

Country Link
US (1) US5849757A (de)
EP (2) EP1304329B1 (de)
KR (1) KR100389773B1 (de)
AT (2) ATE239720T1 (de)
CA (1) CA2212007C (de)
DE (2) DE69637717D1 (de)
DK (1) DK0807630T3 (de)
ES (2) ES2198474T3 (de)
FI (1) FI973207A7 (de)
NO (1) NO314546B1 (de)
PT (1) PT807630E (de)
TW (1) TW487701B (de)
WO (1) WO1996023782A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0911328T3 (da) * 1995-11-22 2006-06-06 Daiichi Seiyaku Co Substituerede aminocycloalkylpyrrolidinderivater
US6121285A (en) 1995-11-22 2000-09-19 Daiichi Pharmaceutical Co., Ltd. Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
TW519542B (en) 1996-09-27 2003-02-01 Daiichi Seiyaku Co Bicyclic amine derivative
ZA984527B (en) * 1997-05-30 1998-12-03 Daiichi Seiyaku Co Substituted cyclobutylamine derivative
ATE423776T1 (de) 1997-09-15 2009-03-15 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
GB9822440D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
AU2940300A (en) * 1999-03-10 2000-09-28 Daiichi Pharmaceutical Co., Ltd. Aminomethylpyrrolidine derivatives having aromatic substituents
KR20010103796A (ko) * 1999-03-17 2001-11-23 스즈키 다다시 5-아미노-8-알킬퀴놀론카복실산 유도체의 제조방법 및제조 중간체
NZ522667A (en) * 2000-03-31 2004-06-25 Daiichi Seiyaku Co Quinolonecarboxylic acid derivative with high antibacterial acitivity and safety and highly stable to light and ahumidity.
IL155976A0 (en) * 2000-11-20 2003-12-23 Daiichi Seiyaku Co Dehalogeno compounds
GB0112834D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
AU2003234810A1 (en) * 2002-05-17 2003-12-02 Daiichi Pharmaceutical Co., Ltd. Process for producing quinolonecarboxylic acid derivative
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US7915418B2 (en) * 2003-06-06 2011-03-29 Daiichi Pharmaceutical Co., Ltd. Intermediates and process for the production of optically active quinolonecarboxylic acid derivatives
EP1634879A4 (de) * 2003-06-19 2007-09-05 Daiichi Seiyaku Co Verfahren zur selektiven einführung eines aminosubstituenten
JP4619952B2 (ja) * 2003-09-29 2011-01-26 第一三共株式会社 8−シアノキノロンカルボン酸誘導体
US7569599B2 (en) * 2003-12-12 2009-08-04 Daiichi Pharmaceutical Co., Ltd. Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates
PT2001862E (pt) 2006-03-28 2011-07-20 Warner Chilcott Co Llc Sais de malato e polimorfos do ácido (3s,5s)-7-[3- amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro- 8-metoxi-4-oxo-3-quinolinocarboxílico
BRPI0709220A2 (pt) 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
PL2097400T3 (pl) * 2007-01-05 2013-11-29 Daiichi Sankyo Co Ltd Skondensowane podstawione pochodne aminopirolidyny
US8278313B2 (en) 2008-03-11 2012-10-02 Abbott Laboratories Macrocyclic spiro pyrimidine derivatives
US8436005B2 (en) 2008-04-03 2013-05-07 Abbott Laboratories Macrocyclic pyrimidine derivatives
US10300155B2 (en) 2015-12-31 2019-05-28 Washington University Alpha-synuclein ligands

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5772981A (en) * 1980-10-22 1982-05-07 Dainippon Pharmaceut Co Ltd 1,8-naphthyridine derivative and its salt
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS60260577A (ja) * 1984-06-06 1985-12-23 Dainippon Pharmaceut Co Ltd 1,8−ナフチリジン誘導体
IL79189A (en) * 1985-06-26 1990-07-12 Daiichi Seiyaku Co Quinoline and/or naphthyridine-4-oxo-3-carboxylic acid derivatives,process for their preparation and pharmaceutical compositions comprising them
JPH0676400B2 (ja) * 1987-08-25 1994-09-28 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
EP0593766B1 (de) * 1991-05-28 2000-09-06 Daiichi Pharmaceutical Co., Ltd. Pyridoncarbonsäurederivate
KR960011370B1 (ko) * 1991-12-31 1996-08-22 재단법인 한국화학연구소 스피로알킬아민 유도체와 그의 제조방법
EP0550016A1 (de) * 1991-12-31 1993-07-07 Korea Research Institute Of Chemical Technology Chinoloncarbonsäure-Derivate und Verfahren zu ihrer Herstellung
AU699636B2 (en) * 1994-02-04 1998-12-10 Dainippon Pharmaceutical Co. Ltd. Bicyclic amino group-substituted pyridonecarboxylic acid derivatives, esters thereof and salts thereof, and bicyclic amines useful as intermediates thereof
DK0911328T3 (da) * 1995-11-22 2006-06-06 Daiichi Seiyaku Co Substituerede aminocycloalkylpyrrolidinderivater

Also Published As

Publication number Publication date
FI973207A7 (fi) 1997-10-01
ES2315432T3 (es) 2009-04-01
CA2212007A1 (en) 1996-08-08
DE69627985T2 (de) 2004-02-19
EP0807630B1 (de) 2003-05-07
NO973530L (no) 1997-10-02
KR19980701860A (ko) 1998-06-25
NO314546B1 (no) 2003-04-07
DE69627985D1 (de) 2003-06-12
EP0807630A4 (de) 1998-05-13
DK0807630T3 (da) 2003-09-01
KR100389773B1 (ko) 2003-10-23
CA2212007C (en) 2004-09-14
EP1304329A2 (de) 2003-04-23
ATE411309T1 (de) 2008-10-15
EP1304329A3 (de) 2004-09-15
EP1304329B1 (de) 2008-10-15
PT807630E (pt) 2003-08-29
TW487701B (en) 2002-05-21
DE69637717D1 (de) 2008-11-27
ES2198474T3 (es) 2004-02-01
US5849757A (en) 1998-12-15
WO1996023782A1 (en) 1996-08-08
FI973207A0 (fi) 1997-08-01
EP0807630A1 (de) 1997-11-19
NO973530D0 (no) 1997-07-31

Similar Documents

Publication Publication Date Title
ATE239720T1 (de) Heterozyklische verbindungen
ATE214055T1 (de) Retinoid-potenzierende verbindungen
FI891980A0 (fi) Menetelmä terapeuttisesti aktiivisten N1-(1,2-cis-2-halogeenisyklopropyyli)substituoitujen pyridonikarboksyylihappojohdannaisten valmistamiseksi
EP1043317A4 (de) Pyridazinderivate und dieselben als aktive bestandteile enthaltende medikamente
NO307379B1 (no) 3-merkapto-1-(1,3-tiazolin-2-yl)azetidin-derivater
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
ID24846A (id) Turunan-turunan bifenilamidina
NO971384D0 (no) Pyrimidinylpyrazol-derivat
DE69623497D1 (de) 1-methylcarbapenem-derivate
ATE127123T1 (de) Biphosphonsäurederivate, produktion und verwendung davon.
DE69319859D1 (de) Neue tetracyclische verbindungen
ATE222588T1 (de) Ein 1-methylcarbapenem-derivat
FI944207A0 (fi) Cyclohexane derivatives
ATE206699T1 (de) Uch-15-verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0807630

Country of ref document: EP

REN Ceased due to non-payment of the annual fee